Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) has been assigned an average recommendation of "Buy" from the six brokerages that are presently covering the firm, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $8.63.
A number of research firms recently weighed in on BIOX. Oppenheimer dropped their price target on Bioceres Crop Solutions from $8.00 to $7.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 22nd. Canaccord Genuity Group reduced their price target on shares of Bioceres Crop Solutions from $7.00 to $6.50 and set a "buy" rating on the stock in a research note on Thursday, February 13th.
Read Our Latest Report on BIOX
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Fourth Sail Capital LP increased its stake in Bioceres Crop Solutions by 25.1% in the 1st quarter. Fourth Sail Capital LP now owns 4,627,669 shares of the company's stock valued at $21,125,000 after buying an additional 928,708 shares during the last quarter. Long Focus Capital Management LLC increased its position in shares of Bioceres Crop Solutions by 11.4% during the first quarter. Long Focus Capital Management LLC now owns 829,748 shares of the company's stock valued at $3,788,000 after acquiring an additional 85,000 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Bioceres Crop Solutions by 9.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 823,916 shares of the company's stock valued at $3,761,000 after acquiring an additional 71,581 shares during the last quarter. Ballast Asset Management LP lifted its holdings in Bioceres Crop Solutions by 23.5% during the fourth quarter. Ballast Asset Management LP now owns 431,887 shares of the company's stock worth $2,620,000 after acquiring an additional 82,187 shares during the period. Finally, Allianz Asset Management GmbH boosted its position in Bioceres Crop Solutions by 77.5% in the first quarter. Allianz Asset Management GmbH now owns 236,717 shares of the company's stock worth $1,081,000 after purchasing an additional 103,337 shares during the last quarter. 17.68% of the stock is currently owned by hedge funds and other institutional investors.
Bioceres Crop Solutions Trading Down 2.2%
NASDAQ:BIOX traded down $0.10 during mid-day trading on Friday, hitting $4.38. The company had a trading volume of 103,830 shares, compared to its average volume of 175,651. The firm has a market cap of $274.67 million, a P/E ratio of 219.11 and a beta of 0.44. The business's fifty day moving average is $4.48 and its two-hundred day moving average is $5.32. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.96 and a current ratio of 1.33. Bioceres Crop Solutions has a fifty-two week low of $3.51 and a fifty-two week high of $11.78.
Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last released its earnings results on Wednesday, May 21st. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.10) by $0.08. The firm had revenue of $59.60 million for the quarter, compared to analysts' expectations of $61.80 million. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.58%. As a group, research analysts expect that Bioceres Crop Solutions will post -0.05 earnings per share for the current year.
Bioceres Crop Solutions Company Profile
(
Get Free ReportBioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Further Reading

Before you consider Bioceres Crop Solutions, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioceres Crop Solutions wasn't on the list.
While Bioceres Crop Solutions currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.